Poly(ADP-ribose) Polymerase 1 (PARP1) Expression in iTreg Plays a Role in the Pathogenesis of Experimental Colitis

被引：0
|
作者：
Larmonier, Claire B.
Shehab, Kareem W.
McFadden, Rita-Marie T.
Jamwal, Deepa R.
Kiela, Pawel R.
Ghishan, Fayez K.
机构：
来源：
GASTROENTEROLOGY | 2015年 / 148卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1764
引用
收藏
页码：S326 / S326
页数：1
相关论文
共 50 条
  • [41] DNA Repair Enzyme Poly(ADP-Ribose) Polymerase 1/2 (PARP1/2)-Targeted Nuclear Imaging and Radiotherapy
    Nguyen, Nghia T.
    Pacelli, Anna
    Nader, Michael
    Kossatz, Susanne
    CANCERS, 2022, 14 (05)
  • [42] Poly(ADP-ribose) polymerase-1 plays a role in suppressing mammary tumourigenesis in mice
    W M Tong
    Y G Yang
    W H Cao
    D Galendo
    L Frappart
    Y Shen
    Z Q Wang
    Oncogene, 2007, 26 : 3857 - 3867
  • [43] PIASy Mediates SUMO-2/3 Conjugation of Poly(ADP-ribose) Polymerase 1 (PARP1) on Mitotic Chromosomes
    Ryu, Hyunju
    Al-Ani, Gada
    Deckert, Katelyn
    Kirkpatrick, Donald
    Gygi, Steven P.
    Dasso, Mary
    Azuma, Yoshiaki
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (19) : 14415 - 14423
  • [44] Poly(ADP-ribose)polymerase-1 (PARP-1) in carcinogenesis: potential role of PARP inhibitors in cancer treatment
    Andreína Peralta-Leal
    María Isabel Rodríguez
    Francisco Javier Oliver
    Clinical and Translational Oncology, 2008, 10 : 318 - 323
  • [45] Poly(ADP-ribose)polymerase-1 (PARP-1) in carcinogenesis:: Potential role of PARP inhibitors in cancer treatment
    Peralta-Leal, Andreina
    Rodriguez, Maria Isabel
    Oliver, Francisco Javier
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (06): : 318 - 323
  • [46] Therapeutic Potentials of Poly (ADP-Ribose) Polymerase 1 (PARP1) Inhibition in Multiple Sclerosis and Animal Models: Concept Revisiting
    Wang, Yan
    Pleasure, David
    Deng, Wenbin
    Guo, Fuzheng
    ADVANCED SCIENCE, 2022, 9 (05)
  • [47] Design, synthesis and SAR evaluation of imidazobenzodiazepines as potent poly(ADP-ribose)polymerase-1 (PARP1) inhibitors.
    Ferraris, D
    Pargas, R
    Dain, D
    Ginski, M
    Lautar, S
    Lee-Wisdom, K
    Liang, S
    Lin, Q
    Lu, XCM
    Morgan, L
    Thomas, B
    Tran, S
    Williams, L
    Xu, W
    Zhang, J
    Zao, YN
    Kalish, VJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U53 - U54
  • [48] INVESTIGATION OF POLY (ADP-RIBOSE) POLYMERASE 1 (PARP1) AS A NOVEL THERAPEUTIC TARGET IN SMALL CELL LUNG CANCER (SCLC)
    Byers, Lauren A.
    Nilsson, Monique
    Fujimoto, Junya
    Saintigny, Pierre
    Wang, Jing
    Diao, Lixia
    Peyton, Michael
    Fan, You-Hong
    Giri, Uma
    Weber, Stephanie
    Duchemann, Boris
    Girard, Luc
    Coombes, Kevin
    Weinstein, John
    Minna, John D.
    Wistuba, Ignacio
    Heymach, John V.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1530 - S1531
  • [49] Poly(ADP-ribose) polymerase-1 plays a role in suppressing mammary tumourigenesis in mice
    Tong, W. M.
    Yang, Y. G.
    Cao, W. H.
    Galendo, D.
    Frappart, L.
    Shen, Y.
    Wang, Z. Q.
    ONCOGENE, 2007, 26 (26) : 3857 - 3867
  • [50] New inhibitors of poly(ADP-ribose) polymerase (PARP)
    Peukert, S
    Schwahn, U
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (11) : 1531 - 1551
12345